Home > Market > Market Stats > Dishman carbogen amcis
  1. S&P BSE SENSEX
    52,727.98 462.26 (0.88%)
  1. NIFTY 50 D
    Delayed by 15 mins

    15,699.25 142.6 (0.92%)
  1. NIFTY BANK D
    Delayed by 15 mins

    33,627.45 492.45 (1.49%)
  1. S&P BSE MIDCAP
    21,803.16 328.34 (1.53%)

DSHM.BO Dishman Carbogen Amcis - Share price

113.5 5.55 (5.14%) 24 JUN 2022 09:59:59
113.8 5.75 (5.32%) 24 JUN 2022 10:26:16
Add Stock to Portfolio / Watchlist on mint Genie + Add Stock
  1. Open price110.0
  2. Prev close107.95
  3. Day high115.1
  4. Day low109.1
  5. 52 week high259.5
  6. 52 week low97.55
  7. Bid quantity0.0
  8. Volume173193
  1. Open price110.0
  2. Prev close108.05
  3. Day high115.3
  4. Day low108.6
  5. 52 week high259.7
  6. 52 week low97.4
  7. Bid quantity113.8
  8. Volume423177

Dishman Carbogen Amcis Financials

Standalone
Revenue
1,912.03
Total Revenue
1,912.03
Costof Revenue Total
524.66
Gross Profit
1,387.37
Selling/ General/ Admin Expenses Total
1,090.79
Depreciation/ Amortization
307.66
Interest Exp( Inc) Net- Operating Total
2.8
Unusual Expense( Income)
22.28
Other Operating Expenses Total
6.04
Total Operating Expense
1,951.71
Operating Income
-39.68
Interest Inc( Exp) Net- Non- Op Total
-311.1
Gain( Loss)on Saleof Assets
1.8
Other Net
5.58
Net Income Before Taxes
-65.03
Provisionfor Income Taxes
100.1
Net Income After Taxes
-165.13
Minority Interest
0
Net Income Before Extra Items
-165.13
Net Income
-165.13
Income Availableto Com Excl Extra Ord
-165.13
Income Availableto Com Incl Extra Ord
-165.13
Diluted Net Income
-165.13
Diluted Weighted Average Shares
15.68
Diluted EPS Excluding Extra Ord Items
-10.53
Diluted Normalized EPS
-3.97
COMPANY INFORMATION
Dishman Carbogen Amcis Limited is engaged in contract research and manufacturing services (CRAMS) and the manufacture and supply of marketable molecules, such as specialty chemicals, vitamins and chemicals, and disinfectants. The Company's segments include CRAMS and Vitamin - D, Bulk Drugs, Quats, Specialty Chemicals and traded goods. The Company assists pharma companies through various stages of drug development from process research and development to late-stage clinical and commercial manufacturing facilities, along with the supply of active pharmaceutical ingredients (APIs) and intermediates. The Company has manufacturing and research facilities in India, Switzerland, France, Netherlands, United Kingdom and China. The Company's subsidiaries include CARBOGEN AMCIS (Shanghai) Co. Ltd, Dishman Infrastructure Ltd., Dishman Carbogen Amcis (Singapore) Pte. Ltd., CARBOGEN AMCIS Holding AG and Dishman Biotech Ltd.
Industry Biotechnology & Drugs
ISIN INE385W01011
BSE code 540701
NSE code DCAL
Global Chief Financial OfficerHarshil   Dalal
Compliance Officer, Company SecretaryShrima   Dave
Global Managing DirectorArpit   Vyas
Whole-time DirectorDeohooti   Vyas

Dishman Carbogen Amcis Announcements

NEWS - Dishman carbogen amcis
View More News
Recommended For You
×
Edit Profile
Get alerts on WhatsApp
Set Preferences My ReadsFeedbackRedeem a Gift CardLogout